ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Ciliary Neurotrophic Factor Market Research Report 2026
Published Date: 2026-01-23
|
Report Code: QYRE-Auto-29W18314
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Ciliary Neurotrophic Factor Market Research Report 2024
BUY CHAPTERS

Global Recombinant Human Ciliary Neurotrophic Factor Market Research Report 2026

Code: QYRE-Auto-29W18314
Report
2026-01-23
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
STEMCELL
Merck
Yeasen
BPS Bioscience
R&D Systems, Inc.
Thermo Fisher Scientific Inc
Cell Guidance Systems LLC
Abcam
ACROBiosystems
Proteintech Group, Inc.
BioLegend
InVitria
SinoBiological
R&D Systems, Inc.

Recombinant Human Ciliary Neurotrophic Factor Market Size

The global Recombinant Human Ciliary Neurotrophic Factor market was valued at US$ 224 million in 2025 and is anticipated to reach US$ 358 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Recombinant Human Ciliary Neurotrophic Factor Market

Recombinant Human Ciliary Neurotrophic Factor Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Human Ciliary Neurotrophic Factor competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant Human Ciliary Neurotrophic Factor: Ciliary neurotrophic factor (CNTF) is a polypeptide originally purified from chick embryonic eye tissue and identified as a trophic factor for embryonic chick ciliated parasympathetic neurons in culture. Subsequent studies have shown that CNTF is a survival factor for other neural cell types, including: dorsal root ganglion sensory neurons, sympathetic ganglion neurons, embryonic motor neurons, major pelvic ganglion neurons, and hippocampal neurons.
The North American market for Recombinant Human Ciliary Neurotrophic Factor is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Recombinant Human Ciliary Neurotrophic Factor is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Recombinant Human Ciliary Neurotrophic Factor include STEMCELL, Merck, YEASEN, BPS Bioscience, R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Recombinant Human Ciliary Neurotrophic Factor market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Human Ciliary Neurotrophic Factor. The Recombinant Human Ciliary Neurotrophic Factor market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Human Ciliary Neurotrophic Factor market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human Ciliary Neurotrophic Factor manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Recombinant Human Ciliary Neurotrophic Factor Market Report

Report Metric Details
Report Name Recombinant Human Ciliary Neurotrophic Factor Market
Accounted market size in 2025 US$ 224 million
Forecasted market size in 2032 US$ 358 million
CAGR 7.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity < 97%
  • Purity ≥ 97%
by Application
  • Laboratory
  • University
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company STEMCELL, Merck, YEASEN, BPS Bioscience, R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, BioLegend, Inc, InVitria, Sinobiological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human Ciliary Neurotrophic Factor manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Recombinant Human Ciliary Neurotrophic Factor sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Ciliary Neurotrophic Factor Market growing?

Ans: The Recombinant Human Ciliary Neurotrophic Factor Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Recombinant Human Ciliary Neurotrophic Factor Market size in 2032?

Ans: The Recombinant Human Ciliary Neurotrophic Factor Market size in 2032 will be US$ 358 million.

Who are the main players in the Recombinant Human Ciliary Neurotrophic Factor Market report?

Ans: The main players in the Recombinant Human Ciliary Neurotrophic Factor Market are STEMCELL, Merck, YEASEN, BPS Bioscience, R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, BioLegend, Inc, InVitria, Sinobiological

What are the Application segmentation covered in the Recombinant Human Ciliary Neurotrophic Factor Market report?

Ans: The Applications covered in the Recombinant Human Ciliary Neurotrophic Factor Market report are Laboratory, University, Others

What are the Type segmentation covered in the Recombinant Human Ciliary Neurotrophic Factor Market report?

Ans: The Types covered in the Recombinant Human Ciliary Neurotrophic Factor Market report are Purity < 97%, Purity ≥ 97%

1 Recombinant Human Ciliary Neurotrophic Factor Market Overview
1.1 Product Definition
1.2 Recombinant Human Ciliary Neurotrophic Factor by Type
1.2.1 Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Type: 2025 vs 2032
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Recombinant Human Ciliary Neurotrophic Factor by Application
1.3.1 Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Application: 2025 vs 2032
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Global Recombinant Human Ciliary Neurotrophic Factor Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Ciliary Neurotrophic Factor Revenue 2021–2032
1.4.2 Global Recombinant Human Ciliary Neurotrophic Factor Sales 2021–2032
1.4.3 Global Recombinant Human Ciliary Neurotrophic Factor Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human Ciliary Neurotrophic Factor Market Competition by Manufacturers
2.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human Ciliary Neurotrophic Factor Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human Ciliary Neurotrophic Factor, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Date of Entry into the Industry
2.8 Global Recombinant Human Ciliary Neurotrophic Factor Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Ciliary Neurotrophic Factor Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human Ciliary Neurotrophic Factor Players Market Share by Revenue
2.8.3 Global Recombinant Human Ciliary Neurotrophic Factor Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Ciliary Neurotrophic Factor Market Scenario by Region
3.1 Global Recombinant Human Ciliary Neurotrophic Factor Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Region: 2021–2032
3.2.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Region: 2021–2026
3.2.2 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Region: 2027–2032
3.3 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Region: 2027–2032
3.4 North America Recombinant Human Ciliary Neurotrophic Factor Market Facts & Figures by Country
3.4.1 North America Recombinant Human Ciliary Neurotrophic Factor Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (2021–2032)
3.4.3 North America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Ciliary Neurotrophic Factor Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Ciliary Neurotrophic Factor Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human Ciliary Neurotrophic Factor Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Ciliary Neurotrophic Factor Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Ciliary Neurotrophic Factor Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Type (2021–2032)
4.1.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Type (2021–2026)
4.1.2 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Type (2027–2032)
4.1.3 Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human Ciliary Neurotrophic Factor Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Application (2021–2032)
5.1.1 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Application (2021–2026)
5.1.2 Global Recombinant Human Ciliary Neurotrophic Factor Sales by Application (2027–2032)
5.1.3 Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human Ciliary Neurotrophic Factor Price by Application (2021–2032)
6 Key Companies Profiled
6.1 STEMCELL
6.1.1 STEMCELL Company Information
6.1.2 STEMCELL Description and Business Overview
6.1.3 STEMCELL Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 STEMCELL Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.1.5 STEMCELL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 YEASEN
6.3.1 YEASEN Company Information
6.3.2 YEASEN Description and Business Overview
6.3.3 YEASEN Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 YEASEN Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.3.5 YEASEN Recent Developments/Updates
6.4 BPS Bioscience
6.4.1 BPS Bioscience Company Information
6.4.2 BPS Bioscience Description and Business Overview
6.4.3 BPS Bioscience Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BPS Bioscience Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.4.5 BPS Bioscience Recent Developments/Updates
6.5 R&D Systems, Inc.
6.5.1 R&D Systems, Inc. Company Information
6.5.2 R&D Systems, Inc. Description and Business Overview
6.5.3 R&D Systems, Inc. Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R&D Systems, Inc. Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.5.5 R&D Systems, Inc. Recent Developments/Updates
6.6 Thermo Fisher Scientific Inc.
6.6.1 Thermo Fisher Scientific Inc. Company Information
6.6.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.6.3 Thermo Fisher Scientific Inc. Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Thermo Fisher Scientific Inc. Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.6.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.7 Cell Guidance Systems LLC
6.7.1 Cell Guidance Systems LLC Company Information
6.7.2 Cell Guidance Systems LLC Description and Business Overview
6.7.3 Cell Guidance Systems LLC Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cell Guidance Systems LLC Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.7.5 Cell Guidance Systems LLC Recent Developments/Updates
6.8 Abcam Limited
6.8.1 Abcam Limited Company Information
6.8.2 Abcam Limited Description and Business Overview
6.8.3 Abcam Limited Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abcam Limited Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.8.5 Abcam Limited Recent Developments/Updates
6.9 ACROBiosystems
6.9.1 ACROBiosystems Company Information
6.9.2 ACROBiosystems Description and Business Overview
6.9.3 ACROBiosystems Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ACROBiosystems Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.9.5 ACROBiosystems Recent Developments/Updates
6.10 Proteintech Group, Inc
6.10.1 Proteintech Group, Inc Company Information
6.10.2 Proteintech Group, Inc Description and Business Overview
6.10.3 Proteintech Group, Inc Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Proteintech Group, Inc Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.10.5 Proteintech Group, Inc Recent Developments/Updates
6.11 BioLegend, Inc
6.11.1 BioLegend, Inc Company Information
6.11.2 BioLegend, Inc Description and Business Overview
6.11.3 BioLegend, Inc Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BioLegend, Inc Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.11.5 BioLegend, Inc Recent Developments/Updates
6.12 InVitria
6.12.1 InVitria Company Information
6.12.2 InVitria Description and Business Overview
6.12.3 InVitria Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 InVitria Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.12.5 InVitria Recent Developments/Updates
6.13 Sinobiological
6.13.1 Sinobiological Company Information
6.13.2 Sinobiological Description and Business Overview
6.13.3 Sinobiological Recombinant Human Ciliary Neurotrophic Factor Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sinobiological Recombinant Human Ciliary Neurotrophic Factor Product Portfolio
6.13.5 Sinobiological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Ciliary Neurotrophic Factor Industry Chain Analysis
7.2 Recombinant Human Ciliary Neurotrophic Factor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Ciliary Neurotrophic Factor Production Mode & Process Analysis
7.4 Recombinant Human Ciliary Neurotrophic Factor Sales and Marketing
7.4.1 Recombinant Human Ciliary Neurotrophic Factor Sales Channels
7.4.2 Recombinant Human Ciliary Neurotrophic Factor Distributors
7.5 Recombinant Human Ciliary Neurotrophic Factor Customer Analysis
8 Recombinant Human Ciliary Neurotrophic Factor Market Dynamics
8.1 Recombinant Human Ciliary Neurotrophic Factor Industry Trends
8.2 Recombinant Human Ciliary Neurotrophic Factor Market Drivers
8.3 Recombinant Human Ciliary Neurotrophic Factor Market Challenges
8.4 Recombinant Human Ciliary Neurotrophic Factor Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
STEMCELL
Merck
Yeasen
BPS Bioscience
R&D Systems, Inc.
Thermo Fisher Scientific Inc
Cell Guidance Systems LLC
Abcam
ACROBiosystems
Proteintech Group, Inc.
BioLegend
InVitria
SinoBiological
R&D Systems, Inc.
List of Tables
 Table 1. Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Recombinant Human Ciliary Neurotrophic Factor Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Recombinant Human Ciliary Neurotrophic Factor Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Recombinant Human Ciliary Neurotrophic Factor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Recombinant Human Ciliary Neurotrophic Factor, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Product Types and Applications
 Table 12. Global Key Manufacturers of Recombinant Human Ciliary Neurotrophic Factor, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Ciliary Neurotrophic Factor Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Ciliary Neurotrophic Factor Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Ciliary Neurotrophic Factor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Recombinant Human Ciliary Neurotrophic Factor Sales by Region (K Units), 2021–2026
 Table 18. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Region (2021–2026)
 Table 19. Global Recombinant Human Ciliary Neurotrophic Factor Sales by Region (K Units), 2027–2032
 Table 20. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Region (2027–2032)
 Table 21. Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Region (2021–2026)
 Table 23. Global Recombinant Human Ciliary Neurotrophic Factor Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Region (2027–2032)
 Table 25. North America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2021–2026
 Table 27. North America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2027–2032
 Table 28. North America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Recombinant Human Ciliary Neurotrophic Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2021–2026
 Table 32. Europe Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2027–2032
 Table 33. Europe Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2021–2026
 Table 42. Latin America Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2027–2032
 Table 43. Latin America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units) by Type (2021–2026)
 Table 51. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units) by Type (2027–2032)
 Table 52. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Type (2021–2026)
 Table 53. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Type (2027–2032)
 Table 54. Global Recombinant Human Ciliary Neurotrophic Factor Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Recombinant Human Ciliary Neurotrophic Factor Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Type (2021–2026)
 Table 57. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Type (2027–2032)
 Table 58. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units) by Application (2021–2026)
 Table 61. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units) by Application (2027–2032)
 Table 62. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Application (2021–2026)
 Table 63. Global Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Application (2027–2032)
 Table 64. Global Recombinant Human Ciliary Neurotrophic Factor Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Recombinant Human Ciliary Neurotrophic Factor Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Application (2021–2026)
 Table 67. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Application (2027–2032)
 Table 68. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Application (2027–2032)
 Table 70. STEMCELL Company Information
 Table 71. STEMCELL Description and Business Overview
 Table 72. STEMCELL Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. STEMCELL Recombinant Human Ciliary Neurotrophic Factor Product
 Table 74. STEMCELL Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Merck Recombinant Human Ciliary Neurotrophic Factor Product
 Table 79. Merck Recent Developments/Updates
 Table 80. YEASEN Company Information
 Table 81. YEASEN Description and Business Overview
 Table 82. YEASEN Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. YEASEN Recombinant Human Ciliary Neurotrophic Factor Product
 Table 84. YEASEN Recent Developments/Updates
 Table 85. BPS Bioscience Company Information
 Table 86. BPS Bioscience Description and Business Overview
 Table 87. BPS Bioscience Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. BPS Bioscience Recombinant Human Ciliary Neurotrophic Factor Product
 Table 89. BPS Bioscience Recent Developments/Updates
 Table 90. R&D Systems, Inc. Company Information
 Table 91. R&D Systems, Inc. Description and Business Overview
 Table 92. R&D Systems, Inc. Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. R&D Systems, Inc. Recombinant Human Ciliary Neurotrophic Factor Product
 Table 94. R&D Systems, Inc. Recent Developments/Updates
 Table 95. Thermo Fisher Scientific Inc. Company Information
 Table 96. Thermo Fisher Scientific Inc. Description and Business Overview
 Table 97. Thermo Fisher Scientific Inc. Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Thermo Fisher Scientific Inc. Recombinant Human Ciliary Neurotrophic Factor Product
 Table 99. Thermo Fisher Scientific Inc. Recent Developments/Updates
 Table 100. Cell Guidance Systems LLC Company Information
 Table 101. Cell Guidance Systems LLC Description and Business Overview
 Table 102. Cell Guidance Systems LLC Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Cell Guidance Systems LLC Recombinant Human Ciliary Neurotrophic Factor Product
 Table 104. Cell Guidance Systems LLC Recent Developments/Updates
 Table 105. Abcam Limited Company Information
 Table 106. Abcam Limited Description and Business Overview
 Table 107. Abcam Limited Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Abcam Limited Recombinant Human Ciliary Neurotrophic Factor Product
 Table 109. Abcam Limited Recent Developments/Updates
 Table 110. ACROBiosystems Company Information
 Table 111. ACROBiosystems Description and Business Overview
 Table 112. ACROBiosystems Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. ACROBiosystems Recombinant Human Ciliary Neurotrophic Factor Product
 Table 114. ACROBiosystems Recent Developments/Updates
 Table 115. Proteintech Group, Inc Company Information
 Table 116. Proteintech Group, Inc Description and Business Overview
 Table 117. Proteintech Group, Inc Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Proteintech Group, Inc Recombinant Human Ciliary Neurotrophic Factor Product
 Table 119. Proteintech Group, Inc Recent Developments/Updates
 Table 120. BioLegend, Inc Company Information
 Table 121. BioLegend, Inc Description and Business Overview
 Table 122. BioLegend, Inc Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. BioLegend, Inc Recombinant Human Ciliary Neurotrophic Factor Product
 Table 124. BioLegend, Inc Recent Developments/Updates
 Table 125. InVitria Company Information
 Table 126. InVitria Description and Business Overview
 Table 127. InVitria Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. InVitria Recombinant Human Ciliary Neurotrophic Factor Product
 Table 129. InVitria Recent Developments/Updates
 Table 130. Sinobiological Company Information
 Table 131. Sinobiological Description and Business Overview
 Table 132. Sinobiological Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Sinobiological Recombinant Human Ciliary Neurotrophic Factor Product
 Table 134. Sinobiological Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Recombinant Human Ciliary Neurotrophic Factor Distributors List
 Table 138. Recombinant Human Ciliary Neurotrophic Factor Customers List
 Table 139. Recombinant Human Ciliary Neurotrophic Factor Market Trends
 Table 140. Recombinant Human Ciliary Neurotrophic Factor Market Drivers
 Table 141. Recombinant Human Ciliary Neurotrophic Factor Market Challenges
 Table 142. Recombinant Human Ciliary Neurotrophic Factor Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Ciliary Neurotrophic Factor
 Figure 2. Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Recombinant Human Ciliary Neurotrophic Factor Market Share by Type: 2025 & 2032
 Figure 4. Purity < 97% Product Picture
 Figure 5. Purity ≥ 97% Product Picture
 Figure 6. Global Recombinant Human Ciliary Neurotrophic Factor Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Recombinant Human Ciliary Neurotrophic Factor Market Share by Application: 2025 & 2032
 Figure 8. Laboratory
 Figure 9. University
 Figure 10. Others
 Figure 11. Global Recombinant Human Ciliary Neurotrophic Factor Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Recombinant Human Ciliary Neurotrophic Factor Market Size (US$ Million), 2021–2032
 Figure 13. Global Recombinant Human Ciliary Neurotrophic Factor Sales (K Units), 2021–2032
 Figure 14. Global Recombinant Human Ciliary Neurotrophic Factor Average Price (US$/Unit), 2021–2032
 Figure 15. Recombinant Human Ciliary Neurotrophic Factor Report Years Considered
 Figure 16. Recombinant Human Ciliary Neurotrophic Factor Sales Share by Manufacturers in 2025
 Figure 17. Global Recombinant Human Ciliary Neurotrophic Factor Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Recombinant Human Ciliary Neurotrophic Factor Players: Market Share by Revenue in Recombinant Human Ciliary Neurotrophic Factor in 2025
 Figure 19. Recombinant Human Ciliary Neurotrophic Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Recombinant Human Ciliary Neurotrophic Factor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Country (2021–2032)
 Figure 22. North America Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Country (2021–2032)
 Figure 23. United States Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Country (2021–2032)
 Figure 26. Europe Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Region (2021–2032)
 Figure 34. China Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Recombinant Human Ciliary Neurotrophic Factor Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Recombinant Human Ciliary Neurotrophic Factor Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Recombinant Human Ciliary Neurotrophic Factor by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Recombinant Human Ciliary Neurotrophic Factor by Type (2021–2032)
 Figure 54. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Recombinant Human Ciliary Neurotrophic Factor by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Recombinant Human Ciliary Neurotrophic Factor by Application (2021–2032)
 Figure 57. Global Recombinant Human Ciliary Neurotrophic Factor Price (US$/Unit) by Application (2021–2032)
 Figure 58. Recombinant Human Ciliary Neurotrophic Factor Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Human Ciliary Neurotrophic Factor Market Research Report 2024
Global Recombinant Human CNTF Market Research Report 2024
Global Brain Derived Neurotrophic Factor BDNF ELISA Kit Market Research Report 2024
Global Human Neuroregulatory Protein Reagents Market Research Report 2025
Global Neurotrophic Keratitis Treatment Market Insights Forecast to 2030
Global Recombinant Human Neuregulin Market Research Report 2024
Neurotrophic Keratitis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Basic Fibroblast Growth Factor Market Research Report 2024
Global Recombinant Human M CSF Protein Market Research Report 2025
Global Recombinant Human Fibroblast Growth Factor Market Research Report 2024
Global Transfer Factor Market Research Report 2024
Global Human Neuregulin Market Research Report 2024
Global Cerebroprotein Hydrolysate for Injection Ⅲ Market Research Report 2024
Global Recombinant Human Neuregulin Kit Market Research Report 2024
Global Human Neuregulin Molecular Reagents Market Research Report 2025
Global Ciliary Neurotrophic Factor Kit Market Research Report 2024
Global Human Fibroblast Growth Factor Market Research Report 2024
Global Neurotrophins Market Research Report 2024
Global Human Fibroblast Growth Factor 2 FGF2 Market Research Report 2024
Global Recombinant Human Fibroblast Growth Factor Kit Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions